- Home
- RGC vs CHWY Comparison
RGC vs CHWY Comparison
Compare RGC & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | CHWY |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.0B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RGC | CHWY |
|---|---|---|
| Price | $23.08 | $25.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $44.82 |
| AVG Volume (30 Days) | 104.8K | ★ 7.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 911.11 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $11,861,335,000.00 |
| Revenue This Year | N/A | $8.37 |
| Revenue Next Year | N/A | $8.28 |
| P/E Ratio | ★ N/A | $57.06 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $9.39 | $23.06 |
| 52 Week High | $950.00 | $48.62 |
Technical Indicators
Market Signals| Indicator | RGC | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 42.31 |
| Support Level | $20.81 | $23.06 |
| Resistance Level | $26.42 | $34.72 |
| Average True Range (ATR) | 2.17 | 1.18 |
| MACD | -0.31 | 0.09 |
| Stochastic Oscillator | 19.38 | 20.51 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.